You are here

Article Text

Article menu
Download PDFPDF
Editorial
Integrated stop smoking interventions are essential to maximise the health benefits from lung cancer screening
  1. Pamela Smith1,
  2. Rachael L Murray2,
  3. Philip A Crosbie3
  1. 1 Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK
  2. 2 School of Medicine, University of Nottingham, Nottingham, UK
  3. 3 Division of Immunology, Immunity to Infection and Respiratory Medicine, University of Manchester, Manchester, UK
  1. Correspondence to Dr Pamela Smith, Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, CF10 3AT, UK; smithp18{at}cardiff.ac.uk

https://doi.org/10.1136/thorax-2023-221037

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In the current issue of Thorax, Williams et al offer timely and much needed evidence regarding the optimal form of smoking cessation intervention in lung cancer screening. In 2022, the UK National Screening Committee recommended targeted screening for lung cancer for those individuals identified to be at high risk and aged 55–74 years. This year the UK Government announced the national roll-out of a targeted lung cancer screening programme and within their recommendations, proposed that smoking cessation service provision should be integrated. The roll-out of such a programme has the potential to not only improve lung cancer outcomes but prevent or reduce the burden of multiple smoking-related diseases, including cardiovascular and respiratory disease as well as multiple cancers through the implementation of colocated smoking cessation support. Evidence suggests that the combination of screening and smoking cessation decreases lung cancer-specific and overall mortality.1

    Evidence shows that lung cancer screening can offer a ‘teachable moment’ for smoking cessation, a brief moment in which motivation to stop smoking can be enhanced.2 3 This unique setting is likely …

    View Full Text

    Footnotes

    • Twitter @DrPhilCrosbie

    • Contributors This article has been written jointly with equal contribution by PS, RLM and PAC.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles